Abstract:Abstract Introduction: Repulsive guidance molecules (RGMs) are involved in embryonic development and iron homeostasis. RGM-A mediates repulsive axonal guidance and neural tube closure, and RGM-C is mutated in juvenile hemochromatosis. RGM-B, also known as Dragon, is a myelin-derived inhibitor of axon growth in the central nervous system. The RGM family was also identified as co-receptors of bone morphogenetic proteins (BMPs), a group of proteins that are involved in development of bones, the differentiation and progression of cancer. However, the role of RGMs played in breast cancer remains unclear. In the present study, we examined the pattern of expression of the RGM family in human breast cancer cells and investigated the impact of Dragon (RGM-B) on BMP-induced cell function in breast cancer cells.Material and Methods: Conventional RT-PCR was performed to screen the expression of RGMs in human breast cancer samples and a range of breast cancer cell lines. Dragon/RGM-B ribozyme transgenes were generated and in order to knock down the Dragon transcript. Subsequently, MDA-231RGMB-Knock-down variants were created by way of the transgenes. A series of cell function assays were employed to investigate any biological effects upon RGM-B knockdown on the breast cancer cells as well as cell's response to recombinant BMP proteins.Results: RGM-A and RGM-C transcripts were barely detectable in breast cancer cell lines (MDA-MB-231 and MCF-7) and tissues. However RGM-B transcripts were expressed in both cell lines. Using anti-RGM-B transgenes, MDA-231RGMB-Knock-down variant cell lines, in which RGM-B transcripts were knocked down, were created. Compared with wild type and control transfection, MDA-231RGMB-Knock-down variants displayed a significant increase in both the adhesiveness and cells growth (p < 0.05, vs the respective controls, for adheresion and for cell growth). Interestingly, RGM-B knockdown did not have any significant effects on the invasiveness of the cells. Finally, wild type breast cancer cells and the RGMB knock down variant cell lines showed a similar response to the treatment with rhBMP-11, indicating that RGM-B is less critical in BMP-11 mediated cell functions.Conclusion: The present study is the first to examine the role of RGM-B in breast cancer and has demonstrated that knock-down of RGMB could enhance breast cancer cells' ability to grow and attach, indicating that RGM-B may act as an inhibitor in breast cancer. This property is unique to RGMB, as this ability is not associated with any other member in the RGM family. Citation Information: Cancer Res 2009;69(24 Suppl):Abstract nr 6158.

RGMb/DRAGON and BMP Signaling

BMP Signaling in the Development and Regeneration of Cranium Bones and Maintenance of Calvarial Stem Cells.

Tgf-Beta and Bmp Signaling in Osteoblast, Skeletal Development, and Bone Formation, Homeostasis and Disease

Roles of Bone Morphogenetic Proteins and Their Receptors in Mammalian Reproduction

Repulsive guidance molecules b (RGMb): molecular mechanism, function and role in diseases

Repulsive Guidance Molecules (rgms) and Their Potential Implication in Cancer As Co-receptor of BMPs

Repulsive Guidance Molecules, Novel Bone Morphogenetic Protein Co-Receptors, Are Key Regulators of the Growth and Aggressiveness of Prostate Cancer Cells

Bone Morphogenetic Protein 6 Gene and Its Role in Mammalian Reproduction

The Role of Dragon (repulsive Guidance Molecule-B, Rgm-B) in Human Breast Cancer

Expression of Repulsive Guidance Molecule B (rgmb) in the Uterus and Ovary During the Estrous Cycle in Rats.

Repulsive Guidance Molecule B (rgmb) Plays Negative Roles in Breast Cancer by Coordinating Bmp Signaling

Dragon (repulsive Guidance Molecule B, RGMb) is a Novel Gene That Promotes Colorectal Cancer Growth

Molecular Recognition in Bone Morphogenetic Protein (bmp)/receptor Interaction

Repulsive Guidance Molecule B (rgmb) is Dispensable for Normal Gonadal Function in Mice1

Retinoic Acid Regulates Bone Morphogenic Protein Signal Duration By Promoting The Degradation Of Phosphorylated Smad1

Bone morphogenetic proteins: Relationship between molecular structure and their osteogenic activity

Potential Prognostic Value of Repulsive Guidance Molecules in Breast Cancer.

Bone Morphogenetic Proteins In The Initiation And Progression Of Breast Cancer

Bone Morphogenetic Protein (BMP) signaling in development and human diseases

Bone Morphogenetic Protein Receptor Signal Transduction in Human Disease

Mechanisms of Compartmentalized Expression of Mrg Class G-protein-coupled Sensory Receptors.